🔥🐔 BizChicken 🐔🔥

Learn About the Corporations Around You

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Corcept Therapeutics Incorporated

Corcept Therapeutics Incorporated logo
Market Cap: High
Employees: Medium

Korlym (mifepristone)

Corcept Therapeutics discovers, develops, and commercializes drugs for treating severe metabolic, oncologic, and neuropsychiatric disorders in the United States, including their product Korlym for Cushing's syndrome.

Tags: Cushing's syndrome, biotechnology, neuropsychiatric disorders, oncology, pharmaceuticals

Symbol: CORT

Recent Price: $50.85

Industry: Biotechnology

CEO: Dr. Joseph K. Belanoff M.D.

Sector: Healthcare

Employees: 352

Address: 149 Commonwealth Drive, Menlo Park, CA 94025

Phone: 650 327 3270

Last updated: 2024-12-31